Cellvizio

Research

News & Events

IBS News Card.png

NEWS - Cellvizio

Mauna Kea Technologies Announces it has Signed its 15th Hospital in Europe for Irritable Bowel Syndrome (IBS) Food Allergy Application

News & Events Card Image (3).png

NEWS - Cellvizio

Mauna Kea Technologies reports second half and full year 2020 financial results and first quarter of 2021 sales

News & Events Card Image (3).png

NEWS - Cellvizio

Mauna Kea Technologies sets up an equity financing facility with Kepler Cheuvreux

News & Events Card Image (3).png

NEWS - Cellvizio

Mauna Kea Technologies to announce 2020 Full Year Results and Q1 2021 Sales on April 22, 2021 after market closes

Covid 19 .png

NEWS - Cellvizio

Mauna Kea Technologies Supports Clinical Research Evaluating the Use of Cellvizio® on COVID-19 Patients with Respiratory Insufficiency

PancCyst News and Event.png

NEWS - Cellvizio

Cellvizio® Combined with Artificial Intelligence Outperforms Standard of Care for Pancreatic Cyst Diagnosis and Risk Stratification

See more